Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Paul J. Hampel
Addition of Venetoclax at Time of Progression in Ibrutinib‐treated Patients With Chronic Lymphocytic Leukemia: Combination Therapy to Prevent Ibrutinib Flare
American Journal of Hematology
Hematology
Autoimmune Cytopenias in Patients With Chronic Lymphocytic Leukaemia Treated With Ibrutinib in Routine Clinical Practice at an Academic Medical Centre
British Journal of Haematology
Hematology
Related publications
Anticoagulant Therapy in Patients With Chronic Lymphocytic Leukemia Receiving Ibrutinib
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Comorbidities Predict Inferior Outcomes in Chronic Lymphocytic Leukemia Treated With Ibrutinib
Cancer
Cancer Research
Oncology
Beyond Ibrutinib Resistance in Chronic Lymphocytic Leukemia
Cancer therapy & Oncology International Journal
Amebic Encephalitis in a Patient With Chronic Lymphocytic Leukemia on Ibrutinib Therapy
Case Reports in Hematology
Arresting the Inflammatory Drive of Chronic Lymphocytic Leukemia With Ibrutinib
Clinical Cancer Research
Cancer Research
Oncology
Ibrutinib Therapy Releases Leukemic Surface IgM From Antigen Drive in Chronic Lymphocytic Leukemia Patients.
Clinical Cancer Research
Cancer Research
Oncology
Experience With Ibrutinib in Patients With Refractory and Recurrent B-Cell Chronic Lymphocytic Leukemia
Medical Council
Phase 2 Study of Acalabrutinib in Ibrutinib-Intolerant Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Comparison of Innate Immunity Changes Following Ibrutinib and Venetoclax Treatment of Relapsed Chronic Lymphocytic Leukaemia
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
